Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSMA and C-11 Choline PET in Prostate Cancer Biochemical Recurrence
NCT03768349Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2019
- Primary completion
- Jul 2021
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
Phase 1, open-label trial of gallium ga-68 gozetotide and radelumin in prostate cancer (PCa), sponsored by Mayo Clinic. Started Jan 2019; status: completed.
02
Drugs
gallium ga-68 gozetotideradelumin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03768349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03768349.